HCPCS Level II
J9038
Injection, axatilimab-csfr, 0.1 mg
Codes near J9038
These sit next to J9038 in the CMS Level II file. All J codes
- J9033Injection, bendamustine hydrochloride, not otherwise specified, 1 mg
- J9034Injection, bendamustine hcl (bendeka), 1 mg
- J9035Injection, bevacizumab, 10 mg
- J9036Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
- J9037Injection, belantamab mafodotin-blmf, 0.5 mg
- J9039Injection, blinatumomab, 1 microgram
- J9040Injection, bleomycin sulfate, 15 units
- J9041Injection, bortezomib, 0.1 mg
- J9042Injection, brentuximab vedotin, 1 mg
- J9043Injection, cabazitaxel, 1 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 50881-0012-10 | Niktimvo | Incyte Corporation | 500 |
| 50881-0023-11 | Niktimvo | Incyte Corporation | 220 |
| 50881-0034-12 | Niktimvo | Incyte Corporation | 90 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.